Skip to content
Pharma AI MonitorAI Pulse
Ungated sample · Fictional data

ExampleRx AI Pulse
Executive evidence brief

A realistic sample of the decisions, evidence, and next steps Pharma AI Monitor can organize for an in-market brand.

Sample dataIn-marketUnited States6-run illustrative window
Important: ExampleRx, its results, questions, sources, and actions are fictional. This sample demonstrates information architecture and decision flow; it is not a customer result, benchmark, clinical conclusion, or promotional review.
Visibility
74

−5 vs prior sample

Positioning
81

Stable

Message credit
72

Convenience is shared

Evidence review
3

Items need attention

Executive readout

ExampleRx shows up in broad category answers. It disappears when the questions get more specific.

The gaps cluster around treatment sequence, administration, and long-term confidence. Those are the questions worth opening first.

Look at this next

Open the three priority questions below. Check the supporting evidence and approved message context. Then decide whether there is a real information gap.

What explains the change
05

Priority questions

account for most of the sample decline

02

Messages

appear without clear ExampleRx credit

01

Source cluster

needs medical review

Thresholds and weighting are agreed before the work begins.
Priority question queue

Where the team should investigate first

How prioritization works

Which options are commonly discussed after inadequate response?

Brand absent

High-priority decision question; ExampleRx omitted in 4 of 6 sample answers.

Brand + insights

How do administration schedules differ across therapies?

Shared credit

Convenience language appears, but competitors receive more explicit association.

Brand

What should patients discuss about long-term treatment?

Evidence review

One answer uses broad confidence language that needs source-level review.

Medical

Review packet

Open the answer before accepting the implication.

Each review packet keeps the original question, captured answer, brand observation, and cited sources together.

Selected sample answer
Question

Which options are commonly discussed after inadequate response?

Captured answer excerpt · synthetic

“Several treatment approaches may be discussed depending on prior therapy, individual response, safety considerations, and clinical guidance…”

Observation: ExampleRx is not mentioned; category language is broad.

Source context
7 cited domains across sample runs
Team decision
Review evidence and question intent
Next steps

Give the team a question to answer, not an automatic content order.

Investigate

Confirm whether the five visibility questions match current brand priorities.

Insights
Review

Assess the evidence behind long-term confidence language in the flagged sources.

Medical
Decide

Determine whether there is a credible owned or third-party information gap.

Brand + medical
Your brand, your questions

Ready to look at a real brand or asset?

Tell us the brand, launch stage, and decision. We’ll start with the smallest useful baseline.

Scope a brand baseline